nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS2—prostate cancer	0.408	1	CbGaD
Ketorolac—PTGS2—Etoposide—prostate cancer	0.0435	0.542	CbGbCtD
Ketorolac—PTGS1—Etoposide—prostate cancer	0.0367	0.458	CbGbCtD
Ketorolac—Tolmetin—CXCL8—prostate cancer	0.00108	0.193	CrCbGaD
Ketorolac—Tolmetin—MPO—prostate cancer	0.000837	0.15	CrCbGaD
Ketorolac—Mebendazole—CYP1A1—prostate cancer	0.000566	0.101	CrCbGaD
Ketorolac—Ketoprofen—CXCL8—prostate cancer	0.000525	0.094	CrCbGaD
Ketorolac—Tiaprofenic acid—PTGS2—prostate cancer	0.000397	0.0711	CrCbGaD
Ketorolac—Nepafenac—PTGS2—prostate cancer	0.000378	0.0676	CrCbGaD
Ketorolac—Mebendazole—CYP3A4—prostate cancer	0.000361	0.0647	CrCbGaD
Ketorolac—Fenbufen—PTGS2—prostate cancer	0.000361	0.0647	CrCbGaD
Ketorolac—Tolmetin—PTGS2—prostate cancer	0.000314	0.0562	CrCbGaD
Ketorolac—Salsalate—PTGS2—prostate cancer	0.000314	0.0562	CrCbGaD
Ketorolac—Suprofen—PTGS2—prostate cancer	0.000301	0.0539	CrCbGaD
Ketorolac—Ketoprofen—PTGS2—prostate cancer	0.000153	0.0274	CrCbGaD
Ketorolac—Somnolence—Docetaxel—prostate cancer	6.03e-05	0.00016	CcSEcCtD
Ketorolac—Discomfort—Prednisone—prostate cancer	6.03e-05	0.00016	CcSEcCtD
Ketorolac—Eye disorder—Epirubicin—prostate cancer	6.02e-05	0.00016	CcSEcCtD
Ketorolac—Hypersensitivity—Etoposide—prostate cancer	6.01e-05	0.00016	CcSEcCtD
Ketorolac—Tinnitus—Epirubicin—prostate cancer	6e-05	0.000159	CcSEcCtD
Ketorolac—Haemoglobin—Doxorubicin—prostate cancer	5.99e-05	0.000159	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Capecitabine—prostate cancer	5.98e-05	0.000159	CcSEcCtD
Ketorolac—Cardiac disorder—Epirubicin—prostate cancer	5.97e-05	0.000159	CcSEcCtD
Ketorolac—Flushing—Epirubicin—prostate cancer	5.97e-05	0.000159	CcSEcCtD
Ketorolac—Rhinitis—Doxorubicin—prostate cancer	5.97e-05	0.000159	CcSEcCtD
Ketorolac—Dyspepsia—Docetaxel—prostate cancer	5.97e-05	0.000158	CcSEcCtD
Ketorolac—Haemorrhage—Doxorubicin—prostate cancer	5.96e-05	0.000158	CcSEcCtD
Ketorolac—Hepatitis—Doxorubicin—prostate cancer	5.96e-05	0.000158	CcSEcCtD
Ketorolac—Insomnia—Capecitabine—prostate cancer	5.94e-05	0.000158	CcSEcCtD
Ketorolac—Paraesthesia—Capecitabine—prostate cancer	5.89e-05	0.000157	CcSEcCtD
Ketorolac—Decreased appetite—Docetaxel—prostate cancer	5.89e-05	0.000157	CcSEcCtD
Ketorolac—Urinary tract disorder—Doxorubicin—prostate cancer	5.88e-05	0.000156	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Docetaxel—prostate cancer	5.85e-05	0.000155	CcSEcCtD
Ketorolac—Asthenia—Etoposide—prostate cancer	5.85e-05	0.000155	CcSEcCtD
Ketorolac—Connective tissue disorder—Doxorubicin—prostate cancer	5.85e-05	0.000155	CcSEcCtD
Ketorolac—Dyspnoea—Capecitabine—prostate cancer	5.85e-05	0.000155	CcSEcCtD
Ketorolac—Anaphylactic shock—Prednisone—prostate cancer	5.85e-05	0.000155	CcSEcCtD
Ketorolac—Oedema—Prednisone—prostate cancer	5.85e-05	0.000155	CcSEcCtD
Ketorolac—Fatigue—Docetaxel—prostate cancer	5.85e-05	0.000155	CcSEcCtD
Ketorolac—Angiopathy—Epirubicin—prostate cancer	5.84e-05	0.000155	CcSEcCtD
Ketorolac—Urethral disorder—Doxorubicin—prostate cancer	5.84e-05	0.000155	CcSEcCtD
Ketorolac—Nausea—Mitoxantrone—prostate cancer	5.83e-05	0.000155	CcSEcCtD
Ketorolac—Immune system disorder—Epirubicin—prostate cancer	5.81e-05	0.000154	CcSEcCtD
Ketorolac—Infection—Prednisone—prostate cancer	5.81e-05	0.000154	CcSEcCtD
Ketorolac—Mediastinal disorder—Epirubicin—prostate cancer	5.8e-05	0.000154	CcSEcCtD
Ketorolac—Constipation—Docetaxel—prostate cancer	5.8e-05	0.000154	CcSEcCtD
Ketorolac—Pain—Docetaxel—prostate cancer	5.8e-05	0.000154	CcSEcCtD
Ketorolac—Dyspepsia—Capecitabine—prostate cancer	5.78e-05	0.000153	CcSEcCtD
Ketorolac—Chills—Epirubicin—prostate cancer	5.78e-05	0.000153	CcSEcCtD
Ketorolac—Pruritus—Etoposide—prostate cancer	5.77e-05	0.000153	CcSEcCtD
Ketorolac—Shock—Prednisone—prostate cancer	5.75e-05	0.000153	CcSEcCtD
Ketorolac—Arrhythmia—Epirubicin—prostate cancer	5.75e-05	0.000153	CcSEcCtD
Ketorolac—Visual impairment—Doxorubicin—prostate cancer	5.74e-05	0.000152	CcSEcCtD
Ketorolac—Nervous system disorder—Prednisone—prostate cancer	5.73e-05	0.000152	CcSEcCtD
Ketorolac—Tachycardia—Prednisone—prostate cancer	5.71e-05	0.000152	CcSEcCtD
Ketorolac—Decreased appetite—Capecitabine—prostate cancer	5.71e-05	0.000152	CcSEcCtD
Ketorolac—Alopecia—Epirubicin—prostate cancer	5.69e-05	0.000151	CcSEcCtD
Ketorolac—Skin disorder—Prednisone—prostate cancer	5.68e-05	0.000151	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Capecitabine—prostate cancer	5.67e-05	0.000151	CcSEcCtD
Ketorolac—Fatigue—Capecitabine—prostate cancer	5.66e-05	0.00015	CcSEcCtD
Ketorolac—Hyperhidrosis—Prednisone—prostate cancer	5.65e-05	0.00015	CcSEcCtD
Ketorolac—Mental disorder—Epirubicin—prostate cancer	5.64e-05	0.00015	CcSEcCtD
Ketorolac—Erythema multiforme—Doxorubicin—prostate cancer	5.63e-05	0.00015	CcSEcCtD
Ketorolac—Pain—Capecitabine—prostate cancer	5.61e-05	0.000149	CcSEcCtD
Ketorolac—Constipation—Capecitabine—prostate cancer	5.61e-05	0.000149	CcSEcCtD
Ketorolac—Erythema—Epirubicin—prostate cancer	5.6e-05	0.000149	CcSEcCtD
Ketorolac—Malnutrition—Epirubicin—prostate cancer	5.6e-05	0.000149	CcSEcCtD
Ketorolac—Feeling abnormal—Docetaxel—prostate cancer	5.59e-05	0.000148	CcSEcCtD
Ketorolac—Diarrhoea—Etoposide—prostate cancer	5.58e-05	0.000148	CcSEcCtD
Ketorolac—Anorexia—Prednisone—prostate cancer	5.57e-05	0.000148	CcSEcCtD
Ketorolac—Eye disorder—Doxorubicin—prostate cancer	5.57e-05	0.000148	CcSEcCtD
Ketorolac—Tinnitus—Doxorubicin—prostate cancer	5.55e-05	0.000147	CcSEcCtD
Ketorolac—Gastrointestinal pain—Docetaxel—prostate cancer	5.54e-05	0.000147	CcSEcCtD
Ketorolac—Flushing—Doxorubicin—prostate cancer	5.53e-05	0.000147	CcSEcCtD
Ketorolac—Cardiac disorder—Doxorubicin—prostate cancer	5.53e-05	0.000147	CcSEcCtD
Ketorolac—Flatulence—Epirubicin—prostate cancer	5.52e-05	0.000147	CcSEcCtD
Ketorolac—Tension—Epirubicin—prostate cancer	5.5e-05	0.000146	CcSEcCtD
Ketorolac—Dysgeusia—Epirubicin—prostate cancer	5.49e-05	0.000146	CcSEcCtD
Ketorolac—Nervousness—Epirubicin—prostate cancer	5.44e-05	0.000145	CcSEcCtD
Ketorolac—Back pain—Epirubicin—prostate cancer	5.42e-05	0.000144	CcSEcCtD
Ketorolac—Feeling abnormal—Capecitabine—prostate cancer	5.41e-05	0.000144	CcSEcCtD
Ketorolac—Angiopathy—Doxorubicin—prostate cancer	5.4e-05	0.000144	CcSEcCtD
Ketorolac—Dizziness—Etoposide—prostate cancer	5.4e-05	0.000143	CcSEcCtD
Ketorolac—Immune system disorder—Doxorubicin—prostate cancer	5.38e-05	0.000143	CcSEcCtD
Ketorolac—Gastrointestinal pain—Capecitabine—prostate cancer	5.37e-05	0.000143	CcSEcCtD
Ketorolac—Mediastinal disorder—Doxorubicin—prostate cancer	5.37e-05	0.000143	CcSEcCtD
Ketorolac—Abdominal pain—Docetaxel—prostate cancer	5.36e-05	0.000142	CcSEcCtD
Ketorolac—Body temperature increased—Docetaxel—prostate cancer	5.36e-05	0.000142	CcSEcCtD
Ketorolac—Chills—Doxorubicin—prostate cancer	5.34e-05	0.000142	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Prednisone—prostate cancer	5.33e-05	0.000141	CcSEcCtD
Ketorolac—Arrhythmia—Doxorubicin—prostate cancer	5.32e-05	0.000141	CcSEcCtD
Ketorolac—Insomnia—Prednisone—prostate cancer	5.29e-05	0.00014	CcSEcCtD
Ketorolac—Vision blurred—Epirubicin—prostate cancer	5.28e-05	0.00014	CcSEcCtD
Ketorolac—Alopecia—Doxorubicin—prostate cancer	5.26e-05	0.00014	CcSEcCtD
Ketorolac—Paraesthesia—Prednisone—prostate cancer	5.25e-05	0.000139	CcSEcCtD
Ketorolac—Mental disorder—Doxorubicin—prostate cancer	5.22e-05	0.000139	CcSEcCtD
Ketorolac—Urticaria—Capecitabine—prostate cancer	5.21e-05	0.000138	CcSEcCtD
Ketorolac—Ill-defined disorder—Epirubicin—prostate cancer	5.2e-05	0.000138	CcSEcCtD
Ketorolac—Body temperature increased—Capecitabine—prostate cancer	5.19e-05	0.000138	CcSEcCtD
Ketorolac—Abdominal pain—Capecitabine—prostate cancer	5.19e-05	0.000138	CcSEcCtD
Ketorolac—Vomiting—Etoposide—prostate cancer	5.19e-05	0.000138	CcSEcCtD
Ketorolac—Erythema—Doxorubicin—prostate cancer	5.18e-05	0.000138	CcSEcCtD
Ketorolac—Malnutrition—Doxorubicin—prostate cancer	5.18e-05	0.000138	CcSEcCtD
Ketorolac—Anaemia—Epirubicin—prostate cancer	5.18e-05	0.000138	CcSEcCtD
Ketorolac—Agitation—Epirubicin—prostate cancer	5.15e-05	0.000137	CcSEcCtD
Ketorolac—Dyspepsia—Prednisone—prostate cancer	5.15e-05	0.000137	CcSEcCtD
Ketorolac—Rash—Etoposide—prostate cancer	5.14e-05	0.000137	CcSEcCtD
Ketorolac—Dermatitis—Etoposide—prostate cancer	5.14e-05	0.000136	CcSEcCtD
Ketorolac—Headache—Etoposide—prostate cancer	5.11e-05	0.000136	CcSEcCtD
Ketorolac—Flatulence—Doxorubicin—prostate cancer	5.11e-05	0.000136	CcSEcCtD
Ketorolac—Tension—Doxorubicin—prostate cancer	5.09e-05	0.000135	CcSEcCtD
Ketorolac—Decreased appetite—Prednisone—prostate cancer	5.08e-05	0.000135	CcSEcCtD
Ketorolac—Dysgeusia—Doxorubicin—prostate cancer	5.08e-05	0.000135	CcSEcCtD
Ketorolac—Malaise—Epirubicin—prostate cancer	5.05e-05	0.000134	CcSEcCtD
Ketorolac—Fatigue—Prednisone—prostate cancer	5.04e-05	0.000134	CcSEcCtD
Ketorolac—Nervousness—Doxorubicin—prostate cancer	5.04e-05	0.000134	CcSEcCtD
Ketorolac—Vertigo—Epirubicin—prostate cancer	5.03e-05	0.000134	CcSEcCtD
Ketorolac—Syncope—Epirubicin—prostate cancer	5.03e-05	0.000133	CcSEcCtD
Ketorolac—Leukopenia—Epirubicin—prostate cancer	5.02e-05	0.000133	CcSEcCtD
Ketorolac—Back pain—Doxorubicin—prostate cancer	5.02e-05	0.000133	CcSEcCtD
Ketorolac—Constipation—Prednisone—prostate cancer	5e-05	0.000133	CcSEcCtD
Ketorolac—Hypersensitivity—Docetaxel—prostate cancer	5e-05	0.000133	CcSEcCtD
Ketorolac—Palpitations—Epirubicin—prostate cancer	4.95e-05	0.000132	CcSEcCtD
Ketorolac—PTGS2—Disease—LDHB—prostate cancer	4.94e-05	0.000382	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RPL12—prostate cancer	4.94e-05	0.000382	CbGpPWpGaD
Ketorolac—Loss of consciousness—Epirubicin—prostate cancer	4.93e-05	0.000131	CcSEcCtD
Ketorolac—Cough—Epirubicin—prostate cancer	4.89e-05	0.00013	CcSEcCtD
Ketorolac—Vision blurred—Doxorubicin—prostate cancer	4.89e-05	0.00013	CcSEcCtD
Ketorolac—PTGS2—Metabolism—TNFRSF21—prostate cancer	4.87e-05	0.000376	CbGpPWpGaD
Ketorolac—Asthenia—Docetaxel—prostate cancer	4.86e-05	0.000129	CcSEcCtD
Ketorolac—Convulsion—Epirubicin—prostate cancer	4.86e-05	0.000129	CcSEcCtD
Ketorolac—Nausea—Etoposide—prostate cancer	4.85e-05	0.000129	CcSEcCtD
Ketorolac—Hypertension—Epirubicin—prostate cancer	4.84e-05	0.000128	CcSEcCtD
Ketorolac—Hypersensitivity—Capecitabine—prostate cancer	4.84e-05	0.000128	CcSEcCtD
Ketorolac—Feeling abnormal—Prednisone—prostate cancer	4.82e-05	0.000128	CcSEcCtD
Ketorolac—Ill-defined disorder—Doxorubicin—prostate cancer	4.81e-05	0.000128	CcSEcCtD
Ketorolac—Pruritus—Docetaxel—prostate cancer	4.8e-05	0.000127	CcSEcCtD
Ketorolac—Anaemia—Doxorubicin—prostate cancer	4.79e-05	0.000127	CcSEcCtD
Ketorolac—Gastrointestinal pain—Prednisone—prostate cancer	4.78e-05	0.000127	CcSEcCtD
Ketorolac—Arthralgia—Epirubicin—prostate cancer	4.77e-05	0.000127	CcSEcCtD
Ketorolac—Chest pain—Epirubicin—prostate cancer	4.77e-05	0.000127	CcSEcCtD
Ketorolac—Myalgia—Epirubicin—prostate cancer	4.77e-05	0.000127	CcSEcCtD
Ketorolac—Agitation—Doxorubicin—prostate cancer	4.76e-05	0.000127	CcSEcCtD
Ketorolac—Anxiety—Epirubicin—prostate cancer	4.75e-05	0.000126	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	4.74e-05	0.000126	CcSEcCtD
Ketorolac—PTGS2—Metabolism—CYP7B1—prostate cancer	4.74e-05	0.000366	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—MTAP—prostate cancer	4.74e-05	0.000366	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	4.73e-05	0.000365	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—HSD3B1—prostate cancer	4.72e-05	0.000364	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SLC22A3—prostate cancer	4.72e-05	0.000364	CbGpPWpGaD
Ketorolac—Discomfort—Epirubicin—prostate cancer	4.71e-05	0.000125	CcSEcCtD
Ketorolac—Asthenia—Capecitabine—prostate cancer	4.71e-05	0.000125	CcSEcCtD
Ketorolac—PTGS2—Disease—TCN2—prostate cancer	4.69e-05	0.000362	CbGpPWpGaD
Ketorolac—Malaise—Doxorubicin—prostate cancer	4.68e-05	0.000124	CcSEcCtD
Ketorolac—Dry mouth—Epirubicin—prostate cancer	4.67e-05	0.000124	CcSEcCtD
Ketorolac—Vertigo—Doxorubicin—prostate cancer	4.66e-05	0.000124	CcSEcCtD
Ketorolac—Syncope—Doxorubicin—prostate cancer	4.65e-05	0.000123	CcSEcCtD
Ketorolac—Urticaria—Prednisone—prostate cancer	4.65e-05	0.000123	CcSEcCtD
Ketorolac—Pruritus—Capecitabine—prostate cancer	4.64e-05	0.000123	CcSEcCtD
Ketorolac—Leukopenia—Doxorubicin—prostate cancer	4.64e-05	0.000123	CcSEcCtD
Ketorolac—Diarrhoea—Docetaxel—prostate cancer	4.64e-05	0.000123	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	4.64e-05	0.000358	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	4.63e-05	0.000357	CbGpPWpGaD
Ketorolac—Body temperature increased—Prednisone—prostate cancer	4.62e-05	0.000123	CcSEcCtD
Ketorolac—Abdominal pain—Prednisone—prostate cancer	4.62e-05	0.000123	CcSEcCtD
Ketorolac—PTGS2—Metabolism—SULT1E1—prostate cancer	4.62e-05	0.000356	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SRD5A1—prostate cancer	4.62e-05	0.000356	CbGpPWpGaD
Ketorolac—Confusional state—Epirubicin—prostate cancer	4.61e-05	0.000122	CcSEcCtD
Ketorolac—Palpitations—Doxorubicin—prostate cancer	4.58e-05	0.000122	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	4.58e-05	0.000353	CbGpPWpGaD
Ketorolac—Anaphylactic shock—Epirubicin—prostate cancer	4.57e-05	0.000121	CcSEcCtD
Ketorolac—Oedema—Epirubicin—prostate cancer	4.57e-05	0.000121	CcSEcCtD
Ketorolac—Loss of consciousness—Doxorubicin—prostate cancer	4.56e-05	0.000121	CcSEcCtD
Ketorolac—Infection—Epirubicin—prostate cancer	4.54e-05	0.000121	CcSEcCtD
Ketorolac—Cough—Doxorubicin—prostate cancer	4.52e-05	0.00012	CcSEcCtD
Ketorolac—PTGS1—Metabolism—TBXAS1—prostate cancer	4.52e-05	0.000349	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTA4—prostate cancer	4.52e-05	0.000349	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	4.51e-05	0.000349	CbGpPWpGaD
Ketorolac—Shock—Epirubicin—prostate cancer	4.5e-05	0.000119	CcSEcCtD
Ketorolac—Convulsion—Doxorubicin—prostate cancer	4.49e-05	0.000119	CcSEcCtD
Ketorolac—Diarrhoea—Capecitabine—prostate cancer	4.49e-05	0.000119	CcSEcCtD
Ketorolac—Nervous system disorder—Epirubicin—prostate cancer	4.48e-05	0.000119	CcSEcCtD
Ketorolac—Dizziness—Docetaxel—prostate cancer	4.48e-05	0.000119	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	4.48e-05	0.000346	CbGpPWpGaD
Ketorolac—Thrombocytopenia—Epirubicin—prostate cancer	4.48e-05	0.000119	CcSEcCtD
Ketorolac—Hypertension—Doxorubicin—prostate cancer	4.48e-05	0.000119	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	4.47e-05	0.000345	CbGpPWpGaD
Ketorolac—Tachycardia—Epirubicin—prostate cancer	4.46e-05	0.000119	CcSEcCtD
Ketorolac—Skin disorder—Epirubicin—prostate cancer	4.44e-05	0.000118	CcSEcCtD
Ketorolac—Hyperhidrosis—Epirubicin—prostate cancer	4.42e-05	0.000117	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	4.42e-05	0.000341	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	4.42e-05	0.000341	CbGpPWpGaD
Ketorolac—Arthralgia—Doxorubicin—prostate cancer	4.41e-05	0.000117	CcSEcCtD
Ketorolac—Chest pain—Doxorubicin—prostate cancer	4.41e-05	0.000117	CcSEcCtD
Ketorolac—Myalgia—Doxorubicin—prostate cancer	4.41e-05	0.000117	CcSEcCtD
Ketorolac—PTGS1—Metabolism—GSTA2—prostate cancer	4.41e-05	0.00034	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—HSD17B3—prostate cancer	4.4e-05	0.00034	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ACSL4—prostate cancer	4.4e-05	0.00034	CbGpPWpGaD
Ketorolac—Anxiety—Doxorubicin—prostate cancer	4.4e-05	0.000117	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	4.38e-05	0.000116	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—TP53—prostate cancer	4.37e-05	0.000338	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	4.37e-05	0.000337	CbGpPWpGaD
Ketorolac—Discomfort—Doxorubicin—prostate cancer	4.36e-05	0.000116	CcSEcCtD
Ketorolac—Anorexia—Epirubicin—prostate cancer	4.36e-05	0.000116	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	4.36e-05	0.000336	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ABCG5—prostate cancer	4.35e-05	0.000336	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SULT1A1—prostate cancer	4.35e-05	0.000336	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	4.35e-05	0.000336	CbGpPWpGaD
Ketorolac—Dizziness—Capecitabine—prostate cancer	4.34e-05	0.000115	CcSEcCtD
Ketorolac—Dry mouth—Doxorubicin—prostate cancer	4.32e-05	0.000115	CcSEcCtD
Ketorolac—Vomiting—Docetaxel—prostate cancer	4.31e-05	0.000114	CcSEcCtD
Ketorolac—Hypersensitivity—Prednisone—prostate cancer	4.31e-05	0.000114	CcSEcCtD
Ketorolac—Rash—Docetaxel—prostate cancer	4.28e-05	0.000114	CcSEcCtD
Ketorolac—Hypotension—Epirubicin—prostate cancer	4.27e-05	0.000113	CcSEcCtD
Ketorolac—Dermatitis—Docetaxel—prostate cancer	4.27e-05	0.000113	CcSEcCtD
Ketorolac—Confusional state—Doxorubicin—prostate cancer	4.27e-05	0.000113	CcSEcCtD
Ketorolac—PTGS1—Metabolism—GSTA1—prostate cancer	4.25e-05	0.000328	CbGpPWpGaD
Ketorolac—Headache—Docetaxel—prostate cancer	4.25e-05	0.000113	CcSEcCtD
Ketorolac—Oedema—Doxorubicin—prostate cancer	4.23e-05	0.000112	CcSEcCtD
Ketorolac—Anaphylactic shock—Doxorubicin—prostate cancer	4.23e-05	0.000112	CcSEcCtD
Ketorolac—PTGS2—Metabolism—PHGDH—prostate cancer	4.22e-05	0.000326	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ARG2—prostate cancer	4.22e-05	0.000326	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—UMPS—prostate cancer	4.22e-05	0.000326	CbGpPWpGaD
Ketorolac—Infection—Doxorubicin—prostate cancer	4.2e-05	0.000112	CcSEcCtD
Ketorolac—PTGS1—Metabolism—NAT2—prostate cancer	4.2e-05	0.000325	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTO1—prostate cancer	4.2e-05	0.000325	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—HSD3B2—prostate cancer	4.2e-05	0.000325	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	4.2e-05	0.000324	CbGpPWpGaD
Ketorolac—Asthenia—Prednisone—prostate cancer	4.2e-05	0.000111	CcSEcCtD
Ketorolac—Vomiting—Capecitabine—prostate cancer	4.17e-05	0.000111	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Epirubicin—prostate cancer	4.17e-05	0.000111	CcSEcCtD
Ketorolac—Shock—Doxorubicin—prostate cancer	4.16e-05	0.000111	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	4.16e-05	0.000321	CbGpPWpGaD
Ketorolac—Nervous system disorder—Doxorubicin—prostate cancer	4.15e-05	0.00011	CcSEcCtD
Ketorolac—Thrombocytopenia—Doxorubicin—prostate cancer	4.14e-05	0.00011	CcSEcCtD
Ketorolac—PTGS2—Metabolism—LDHB—prostate cancer	4.14e-05	0.00032	CbGpPWpGaD
Ketorolac—Rash—Capecitabine—prostate cancer	4.14e-05	0.00011	CcSEcCtD
Ketorolac—Pruritus—Prednisone—prostate cancer	4.14e-05	0.00011	CcSEcCtD
Ketorolac—Insomnia—Epirubicin—prostate cancer	4.14e-05	0.00011	CcSEcCtD
Ketorolac—Dermatitis—Capecitabine—prostate cancer	4.14e-05	0.00011	CcSEcCtD
Ketorolac—Tachycardia—Doxorubicin—prostate cancer	4.13e-05	0.00011	CcSEcCtD
Ketorolac—Headache—Capecitabine—prostate cancer	4.11e-05	0.000109	CcSEcCtD
Ketorolac—Skin disorder—Doxorubicin—prostate cancer	4.11e-05	0.000109	CcSEcCtD
Ketorolac—Paraesthesia—Epirubicin—prostate cancer	4.11e-05	0.000109	CcSEcCtD
Ketorolac—Hyperhidrosis—Doxorubicin—prostate cancer	4.09e-05	0.000109	CcSEcCtD
Ketorolac—Dyspnoea—Epirubicin—prostate cancer	4.08e-05	0.000108	CcSEcCtD
Ketorolac—Somnolence—Epirubicin—prostate cancer	4.07e-05	0.000108	CcSEcCtD
Ketorolac—PTGS2—Metabolism—CYP3A5—prostate cancer	4.06e-05	0.000314	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	4.04e-05	0.000312	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	4.04e-05	0.000312	CbGpPWpGaD
Ketorolac—Anorexia—Doxorubicin—prostate cancer	4.03e-05	0.000107	CcSEcCtD
Ketorolac—PTGS1—Metabolism—PLCB2—prostate cancer	4.03e-05	0.000311	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—LRP2—prostate cancer	4.03e-05	0.000311	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP2C18—prostate cancer	4.03e-05	0.000311	CbGpPWpGaD
Ketorolac—Nausea—Docetaxel—prostate cancer	4.03e-05	0.000107	CcSEcCtD
Ketorolac—Dyspepsia—Epirubicin—prostate cancer	4.03e-05	0.000107	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—IL6—prostate cancer	4e-05	0.000309	CbGpPWpGaD
Ketorolac—Diarrhoea—Prednisone—prostate cancer	4e-05	0.000106	CcSEcCtD
Ketorolac—PTGS2—Disease—GSTO1—prostate cancer	3.98e-05	0.000308	CbGpPWpGaD
Ketorolac—Decreased appetite—Epirubicin—prostate cancer	3.98e-05	0.000106	CcSEcCtD
Ketorolac—Hypotension—Doxorubicin—prostate cancer	3.95e-05	0.000105	CcSEcCtD
Ketorolac—PTGS1—Metabolism—P4HB—prostate cancer	3.95e-05	0.000305	CbGpPWpGaD
Ketorolac—Gastrointestinal disorder—Epirubicin—prostate cancer	3.95e-05	0.000105	CcSEcCtD
Ketorolac—Fatigue—Epirubicin—prostate cancer	3.94e-05	0.000105	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	3.94e-05	0.000304	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PDHA1—prostate cancer	3.92e-05	0.000303	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—UCP3—prostate cancer	3.92e-05	0.000303	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTA3—prostate cancer	3.92e-05	0.000303	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—TCN2—prostate cancer	3.92e-05	0.000303	CbGpPWpGaD
Ketorolac—Pain—Epirubicin—prostate cancer	3.91e-05	0.000104	CcSEcCtD
Ketorolac—Constipation—Epirubicin—prostate cancer	3.91e-05	0.000104	CcSEcCtD
Ketorolac—Nausea—Capecitabine—prostate cancer	3.9e-05	0.000104	CcSEcCtD
Ketorolac—Dizziness—Prednisone—prostate cancer	3.87e-05	0.000103	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Doxorubicin—prostate cancer	3.86e-05	0.000102	CcSEcCtD
Ketorolac—PTGS1—Metabolism—SLC22A1—prostate cancer	3.84e-05	0.000297	CbGpPWpGaD
Ketorolac—Insomnia—Doxorubicin—prostate cancer	3.83e-05	0.000102	CcSEcCtD
Ketorolac—PTGS2—Disease—LRP2—prostate cancer	3.82e-05	0.000295	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.8e-05	0.000293	CbGpPWpGaD
Ketorolac—Paraesthesia—Doxorubicin—prostate cancer	3.8e-05	0.000101	CcSEcCtD
Ketorolac—Dyspnoea—Doxorubicin—prostate cancer	3.77e-05	0.0001	CcSEcCtD
Ketorolac—Feeling abnormal—Epirubicin—prostate cancer	3.77e-05	0.0001	CcSEcCtD
Ketorolac—Somnolence—Doxorubicin—prostate cancer	3.76e-05	9.99e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—SULT2A1—prostate cancer	3.75e-05	0.000289	CbGpPWpGaD
Ketorolac—PTGS2—Disease—P4HB—prostate cancer	3.75e-05	0.000289	CbGpPWpGaD
Ketorolac—PTGS2—Disease—EIF2AK2—prostate cancer	3.75e-05	0.000289	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RPL10—prostate cancer	3.75e-05	0.000289	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—HSD3B1—prostate cancer	3.74e-05	0.000289	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SLC22A3—prostate cancer	3.74e-05	0.000289	CbGpPWpGaD
Ketorolac—Gastrointestinal pain—Epirubicin—prostate cancer	3.74e-05	9.93e-05	CcSEcCtD
Ketorolac—Dyspepsia—Doxorubicin—prostate cancer	3.72e-05	9.89e-05	CcSEcCtD
Ketorolac—Vomiting—Prednisone—prostate cancer	3.72e-05	9.87e-05	CcSEcCtD
Ketorolac—Rash—Prednisone—prostate cancer	3.69e-05	9.79e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—MED12—prostate cancer	3.69e-05	0.000285	CbGpPWpGaD
Ketorolac—Dermatitis—Prednisone—prostate cancer	3.68e-05	9.78e-05	CcSEcCtD
Ketorolac—Decreased appetite—Doxorubicin—prostate cancer	3.68e-05	9.77e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—HIST1H2BG—prostate cancer	3.68e-05	0.000284	CbGpPWpGaD
Ketorolac—Headache—Prednisone—prostate cancer	3.66e-05	9.73e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—GNG5—prostate cancer	3.66e-05	0.000282	CbGpPWpGaD
Ketorolac—Gastrointestinal disorder—Doxorubicin—prostate cancer	3.65e-05	9.7e-05	CcSEcCtD
Ketorolac—Fatigue—Doxorubicin—prostate cancer	3.65e-05	9.69e-05	CcSEcCtD
Ketorolac—Urticaria—Epirubicin—prostate cancer	3.63e-05	9.65e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	3.63e-05	0.000281	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	3.62e-05	0.00028	CbGpPWpGaD
Ketorolac—Pain—Doxorubicin—prostate cancer	3.62e-05	9.61e-05	CcSEcCtD
Ketorolac—Constipation—Doxorubicin—prostate cancer	3.62e-05	9.61e-05	CcSEcCtD
Ketorolac—Abdominal pain—Epirubicin—prostate cancer	3.62e-05	9.6e-05	CcSEcCtD
Ketorolac—Body temperature increased—Epirubicin—prostate cancer	3.62e-05	9.6e-05	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	3.61e-05	0.000279	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—TBXAS1—prostate cancer	3.59e-05	0.000277	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTA4—prostate cancer	3.59e-05	0.000277	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HIST1H4H—prostate cancer	3.55e-05	0.000274	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NPPA—prostate cancer	3.55e-05	0.000274	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	3.54e-05	0.000273	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NCOA3—prostate cancer	3.52e-05	0.000272	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	3.51e-05	0.000271	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTA2—prostate cancer	3.5e-05	0.00027	CbGpPWpGaD
Ketorolac—Feeling abnormal—Doxorubicin—prostate cancer	3.49e-05	9.26e-05	CcSEcCtD
Ketorolac—Nausea—Prednisone—prostate cancer	3.47e-05	9.22e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.46e-05	0.000267	CbGpPWpGaD
Ketorolac—Gastrointestinal pain—Doxorubicin—prostate cancer	3.46e-05	9.19e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—ABCG5—prostate cancer	3.46e-05	0.000267	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SULT1A1—prostate cancer	3.46e-05	0.000267	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTA1—prostate cancer	3.37e-05	0.000261	CbGpPWpGaD
Ketorolac—Hypersensitivity—Epirubicin—prostate cancer	3.37e-05	8.95e-05	CcSEcCtD
Ketorolac—Urticaria—Doxorubicin—prostate cancer	3.36e-05	8.93e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—HPGDS—prostate cancer	3.36e-05	0.00026	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	3.35e-05	0.000258	CbGpPWpGaD
Ketorolac—Abdominal pain—Doxorubicin—prostate cancer	3.35e-05	8.88e-05	CcSEcCtD
Ketorolac—Body temperature increased—Doxorubicin—prostate cancer	3.35e-05	8.88e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—CYP2C19—prostate cancer	3.34e-05	0.000258	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NAT2—prostate cancer	3.34e-05	0.000258	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTO1—prostate cancer	3.34e-05	0.000258	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—HSD3B2—prostate cancer	3.34e-05	0.000258	CbGpPWpGaD
Ketorolac—Asthenia—Epirubicin—prostate cancer	3.28e-05	8.71e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—GSTT1—prostate cancer	3.26e-05	0.000252	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ACHE—prostate cancer	3.26e-05	0.000252	CbGpPWpGaD
Ketorolac—Pruritus—Epirubicin—prostate cancer	3.24e-05	8.59e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—CYP2A6—prostate cancer	3.22e-05	0.000249	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.21e-05	0.000248	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	3.21e-05	0.000248	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PLCB2—prostate cancer	3.2e-05	0.000247	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP2C18—prostate cancer	3.2e-05	0.000247	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—LRP2—prostate cancer	3.2e-05	0.000247	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—P4HB—prostate cancer	3.14e-05	0.000242	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—AKR1C3—prostate cancer	3.13e-05	0.000242	CbGpPWpGaD
Ketorolac—Diarrhoea—Epirubicin—prostate cancer	3.13e-05	8.31e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—PRKACB—prostate cancer	3.12e-05	0.000241	CbGpPWpGaD
Ketorolac—Hypersensitivity—Doxorubicin—prostate cancer	3.12e-05	8.28e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—CYP17A1—prostate cancer	3.09e-05	0.000238	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	3.07e-05	0.000237	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SLC22A1—prostate cancer	3.05e-05	0.000236	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.04e-05	0.000235	CbGpPWpGaD
Ketorolac—Asthenia—Doxorubicin—prostate cancer	3.04e-05	8.06e-05	CcSEcCtD
Ketorolac—Dizziness—Epirubicin—prostate cancer	3.02e-05	8.03e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—TGFBR1—prostate cancer	3.02e-05	0.000233	CbGpPWpGaD
Ketorolac—PTGS2—Disease—B2M—prostate cancer	3.02e-05	0.000233	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.02e-05	0.000233	CbGpPWpGaD
Ketorolac—Pruritus—Doxorubicin—prostate cancer	2.99e-05	7.95e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—SULT2A1—prostate cancer	2.97e-05	0.00023	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	2.97e-05	0.00023	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RPS19—prostate cancer	2.97e-05	0.000229	CbGpPWpGaD
Ketorolac—PTGS2—Disease—AKR1C3—prostate cancer	2.97e-05	0.000229	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PRKACB—prostate cancer	2.96e-05	0.000228	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NCOA2—prostate cancer	2.94e-05	0.000227	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—MED12—prostate cancer	2.93e-05	0.000226	CbGpPWpGaD
Ketorolac—Vomiting—Epirubicin—prostate cancer	2.91e-05	7.72e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—GNG5—prostate cancer	2.9e-05	0.000224	CbGpPWpGaD
Ketorolac—Diarrhoea—Doxorubicin—prostate cancer	2.9e-05	7.69e-05	CcSEcCtD
Ketorolac—Rash—Epirubicin—prostate cancer	2.88e-05	7.66e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—PPP3CA—prostate cancer	2.88e-05	0.000222	CbGpPWpGaD
Ketorolac—Dermatitis—Epirubicin—prostate cancer	2.88e-05	7.65e-05	CcSEcCtD
Ketorolac—Headache—Epirubicin—prostate cancer	2.86e-05	7.61e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—SLC5A5—prostate cancer	2.8e-05	0.000217	CbGpPWpGaD
Ketorolac—Dizziness—Doxorubicin—prostate cancer	2.8e-05	7.43e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—NCOA3—prostate cancer	2.8e-05	0.000216	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PRKCZ—prostate cancer	2.79e-05	0.000215	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.75e-05	0.000212	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP2E1—prostate cancer	2.74e-05	0.000212	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CALR—prostate cancer	2.74e-05	0.000211	CbGpPWpGaD
Ketorolac—Nausea—Epirubicin—prostate cancer	2.72e-05	7.21e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—NQO1—prostate cancer	2.71e-05	0.000209	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FGFR4—prostate cancer	2.69e-05	0.000208	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PARP1—prostate cancer	2.69e-05	0.000208	CbGpPWpGaD
Ketorolac—Vomiting—Doxorubicin—prostate cancer	2.69e-05	7.14e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—TH—prostate cancer	2.67e-05	0.000206	CbGpPWpGaD
Ketorolac—Rash—Doxorubicin—prostate cancer	2.67e-05	7.09e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—HPGDS—prostate cancer	2.67e-05	0.000206	CbGpPWpGaD
Ketorolac—Dermatitis—Doxorubicin—prostate cancer	2.67e-05	7.08e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—CALCA—prostate cancer	2.66e-05	0.000205	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.65e-05	0.000205	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP2C19—prostate cancer	2.65e-05	0.000205	CbGpPWpGaD
Ketorolac—Headache—Doxorubicin—prostate cancer	2.65e-05	7.04e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—CYP3A4—prostate cancer	2.64e-05	0.000204	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.63e-05	0.000203	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP1B1—prostate cancer	2.6e-05	0.000201	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTT1—prostate cancer	2.59e-05	0.0002	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ACHE—prostate cancer	2.59e-05	0.0002	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP2A6—prostate cancer	2.56e-05	0.000198	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HSPA1A—prostate cancer	2.55e-05	0.000197	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.55e-05	0.000197	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GGT1—prostate cancer	2.52e-05	0.000194	CbGpPWpGaD
Ketorolac—Nausea—Doxorubicin—prostate cancer	2.51e-05	6.67e-05	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	2.51e-05	0.000194	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—AKR1C3—prostate cancer	2.49e-05	0.000192	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NCOA1—prostate cancer	2.48e-05	0.000191	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PRKACB—prostate cancer	2.47e-05	0.000191	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP17A1—prostate cancer	2.45e-05	0.000189	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CASP9—prostate cancer	2.45e-05	0.000189	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP19A1—prostate cancer	2.44e-05	0.000189	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.42e-05	0.000187	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PRKCQ—prostate cancer	2.37e-05	0.000183	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—RXRA—prostate cancer	2.36e-05	0.000182	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NCOA2—prostate cancer	2.33e-05	0.00018	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.29e-05	0.000177	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—COMT—prostate cancer	2.27e-05	0.000175	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTP1—prostate cancer	2.26e-05	0.000174	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FGF10—prostate cancer	2.25e-05	0.000174	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SLC5A5—prostate cancer	2.23e-05	0.000172	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ITPR1—prostate cancer	2.22e-05	0.000172	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.19e-05	0.000169	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP2E1—prostate cancer	2.17e-05	0.000168	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NQO1—prostate cancer	2.15e-05	0.000166	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TGFBR2—prostate cancer	2.14e-05	0.000165	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—TH—prostate cancer	2.12e-05	0.000164	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ITPR1—prostate cancer	2.11e-05	0.000163	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.11e-05	0.000163	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—TYMS—prostate cancer	2.1e-05	0.000162	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP3A4—prostate cancer	2.1e-05	0.000162	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTM1—prostate cancer	2.08e-05	0.00016	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP1B1—prostate cancer	2.06e-05	0.000159	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—LPL—prostate cancer	2.04e-05	0.000157	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GGT1—prostate cancer	2e-05	0.000154	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP1A1—prostate cancer	1.97e-05	0.000152	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NCOA1—prostate cancer	1.97e-05	0.000152	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ERCC2—prostate cancer	1.95e-05	0.000151	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP19A1—prostate cancer	1.94e-05	0.00015	CbGpPWpGaD
Ketorolac—PTGS2—Disease—LPL—prostate cancer	1.93e-05	0.000149	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PDGFRB—prostate cancer	1.91e-05	0.000148	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—RXRA—prostate cancer	1.87e-05	0.000144	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ERCC2—prostate cancer	1.85e-05	0.000143	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—MTHFR—prostate cancer	1.83e-05	0.000142	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.82e-05	0.000141	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ERBB3—prostate cancer	1.81e-05	0.00014	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FGFR2—prostate cancer	1.81e-05	0.00014	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—COMT—prostate cancer	1.8e-05	0.000139	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PPARA—prostate cancer	1.8e-05	0.000139	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTP1—prostate cancer	1.79e-05	0.000138	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ITPR1—prostate cancer	1.76e-05	0.000136	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MTHFR—prostate cancer	1.74e-05	0.000134	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.74e-05	0.000134	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TERT—prostate cancer	1.73e-05	0.000134	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CAV1—prostate cancer	1.69e-05	0.000131	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—TYMS—prostate cancer	1.67e-05	0.000129	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HIF1A—prostate cancer	1.66e-05	0.000128	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTM1—prostate cancer	1.65e-05	0.000127	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—LPL—prostate cancer	1.62e-05	0.000125	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.62e-05	0.000125	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CAV1—prostate cancer	1.6e-05	0.000124	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP1A1—prostate cancer	1.56e-05	0.000121	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ERCC2—prostate cancer	1.55e-05	0.00012	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CG—prostate cancer	1.54e-05	0.000119	CbGpPWpGaD
Ketorolac—PTGS2—Disease—BAD—prostate cancer	1.51e-05	0.000117	CbGpPWpGaD
Ketorolac—PTGS2—Disease—APC—prostate cancer	1.46e-05	0.000113	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—INS—prostate cancer	1.46e-05	0.000113	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—MTHFR—prostate cancer	1.46e-05	0.000112	CbGpPWpGaD
Ketorolac—PTGS2—Disease—EGF—prostate cancer	1.44e-05	0.000112	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IRS1—prostate cancer	1.44e-05	0.000112	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CREBBP—prostate cancer	1.43e-05	0.00011	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PPARA—prostate cancer	1.43e-05	0.00011	CbGpPWpGaD
Ketorolac—PTGS2—Disease—GSK3B—prostate cancer	1.4e-05	0.000108	CbGpPWpGaD
Ketorolac—PTGS2—Disease—INS—prostate cancer	1.38e-05	0.000107	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CD—prostate cancer	1.36e-05	0.000105	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CREBBP—prostate cancer	1.35e-05	0.000105	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CAV1—prostate cancer	1.34e-05	0.000104	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MAP2K1—prostate cancer	1.29e-05	9.99e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CD—prostate cancer	1.28e-05	9.92e-05	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.28e-05	9.91e-05	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NOS3—prostate cancer	1.28e-05	9.88e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SERPINE1—prostate cancer	1.27e-05	9.81e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FGF2—prostate cancer	1.23e-05	9.5e-05	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CG—prostate cancer	1.22e-05	9.45e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NOS3—prostate cancer	1.21e-05	9.37e-05	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CB—prostate cancer	1.18e-05	9.12e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—JAK2—prostate cancer	1.18e-05	9.1e-05	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PTGS2—prostate cancer	1.17e-05	9.04e-05	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—INS—prostate cancer	1.16e-05	8.95e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MDM2—prostate cancer	1.15e-05	8.89e-05	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CREBBP—prostate cancer	1.13e-05	8.76e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ERBB2—prostate cancer	1.13e-05	8.76e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CB—prostate cancer	1.12e-05	8.65e-05	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CD—prostate cancer	1.08e-05	8.31e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CDKN1B—prostate cancer	1.05e-05	8.11e-05	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PTEN—prostate cancer	1.02e-05	7.88e-05	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NOS3—prostate cancer	1.02e-05	7.84e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CTNNB1—prostate cancer	9.93e-06	7.67e-05	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—EP300—prostate cancer	9.73e-06	7.52e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CDKN1A—prostate cancer	9.7e-06	7.49e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PTEN—prostate cancer	9.68e-06	7.47e-05	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CB—prostate cancer	9.38e-06	7.24e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—EP300—prostate cancer	9.23e-06	7.13e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SRC—prostate cancer	8.97e-06	6.93e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—STAT3—prostate cancer	8.65e-06	6.68e-05	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PTEN—prostate cancer	8.1e-06	6.26e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MYC—prostate cancer	8.04e-06	6.21e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TGFB1—prostate cancer	8.02e-06	6.19e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—EGFR—prostate cancer	7.87e-06	6.07e-05	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—EP300—prostate cancer	7.73e-06	5.97e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—KRAS—prostate cancer	7.43e-06	5.74e-05	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CA—prostate cancer	7.2e-06	5.56e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CA—prostate cancer	6.83e-06	5.27e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IL6—prostate cancer	6.04e-06	4.67e-05	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—AKT1—prostate cancer	5.88e-06	4.54e-05	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CA—prostate cancer	5.72e-06	4.41e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—AKT1—prostate cancer	5.58e-06	4.31e-05	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—AKT1—prostate cancer	4.67e-06	3.61e-05	CbGpPWpGaD
